Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
NCT ID: NCT01851967
Last Updated: 2016-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
112 participants
INTERVENTIONAL
2014-09-30
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis 1: Participants enrolled in MoodGYM will show a significant decrease in depressive symptoms after completion of the 5 modules.
Hypothesis 2: Participants enrolled in MoodGYM will show significantly improved dysfunctional thinking.
Hypothesis 3: Participants enrolled in MoodGym will rate this program as culturally acceptable.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MoodGYM
This study is a single-arm intervnetion. All subjects will be assigned to receive six weeks of online CBT through MoodGYM.
MoodGYM
MoodGYM, a publicly-available online CBT program developed by the Centre for Mental Health Research at The Australian National University has been shown by multiple studies to be effective in reducing symptoms of depression. MoodGYM consists of five interactive modules. Participants will be asked to complete one module each week and progress through the program sequentially.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MoodGYM
MoodGYM, a publicly-available online CBT program developed by the Centre for Mental Health Research at The Australian National University has been shown by multiple studies to be effective in reducing symptoms of depression. MoodGYM consists of five interactive modules. Participants will be asked to complete one module each week and progress through the program sequentially.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 18 years of age
* Proficiency in Chinese, including the ability to read Chinese
* Access to computer and internet
* Scores \> 10 on the Chinese bilingual patient health questionnaire -9 item (PHQ-9)
Exclusion Criteria
* Using illicit drugs or consumption \> 3 standard drinks in a day
* Currently experiencing a psychotic illness
* Past or current history of schizophrenia or bipolar disorder
* ECT during the last year
* Current active suicidal or self-injurious potential necessitating immediate face-to-face treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Albert Yeung
Principle Investigator / Psychiatrist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital Depression Clinical and Research Program
Boston, Massachusetts, United States
Ying Wang
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-P-002340
Identifier Type: -
Identifier Source: org_study_id